Impact Partnership Wealth LLC Buys Shares of 1,695 UnitedHealth Group Incorporated (NYSE:UNH)

Impact Partnership Wealth LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,695 shares of the healthcare conglomerate's stock, valued at approximately $888,000.

A number of other institutional investors also recently added to or reduced their stakes in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $30,000. Kapitalo Investimentos Ltda purchased a new position in shares of UnitedHealth Group during the 4th quarter worth $41,000. Finally, Copia Wealth Management acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth $42,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 2.0%

NYSE UNH traded down $5.62 during trading hours on Friday, reaching $282.45. The company's stock had a trading volume of 14,902,160 shares, compared to its average volume of 7,818,498. The firm has a fifty day simple moving average of $304.47 and a 200-day simple moving average of $433.39. The stock has a market cap of $256.22 billion, a P/E ratio of 11.83, a P/E/G ratio of 1.38 and a beta of 0.45. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the prior year, the company posted $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.13%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is presently 37.02%.

Analyst Ratings Changes

A number of research firms have weighed in on UNH. TD Securities reissued a "hold" rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. KeyCorp lowered their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Argus downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, Wolfe Research dropped their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $394.43.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.